Navigation Links
IRIDEX Announces Third Quarter 2010 Conference Call and Release Date
Date:10/28/2010

MOUNTAIN VIEW, Calif., Oct. 28 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release its third quarter 2010 financial results after the market closes on Thursday, November 4, 2010.  In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, November 4, 2010 to discuss the results of the quarter and other business developments.

Interested parties may access the live conference call via telephone by dialing (800) 762-9441 U.S. or (480) 629-9674 (International) and quoting Conference ID 4380709, or by visiting the Company's website at www.iridex.com.  A telephone replay will be available beginning on Thursday, November 4, 2010 through Thursday, November 11, 2010 by dialing (800) 406-7325 (US) or (303) 590-3030 (International) and entering Access Code 4380709.

About IRIDEX

IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems and delivery devices. We provide solutions for multiple specialties, including ophthalmology, dermatology and otolaryngology. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. IRIDEX Introduces New ENT Laser Delivery Devices at AAO-HNSF Annual Meeting
2. IRIDEX Introduces Modular Multi-Wavelength Laser Solution at the American Academy of Ophthalmology
3. IRIDEX Introduces IQ 532 Dual Port Green Laser System at the American Academy of Ophthalmology
4. Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors
5. IRIDEX Announces Fourth Quarter and Full Year 2009 Conference Call and Release Date
6. IRIDEX Reports Fourth Quarter and Full Year 2009 Financial Results
7. IRIDEX Announces First Quarter 2010 Conference Call and Release Date
8. IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
9. IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
10. IRIDEX Announces Second Quarter 2010 Conference Call and Release Date
11. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/256szd/corporate ... Reputation of Pharma in 2014 - a Perspective of ... to their offering. For the first time, ... corporate reputation of the pharmaceutical industry held by patient ... views of patient organisations representing all therapy areas. ...
(Date:4/16/2015)... April 16, 2015 Mindray Medical International ... and marketer of medical devices worldwide, announced today ... Exchange Commission an Annual Report on Form 20-F that ... 31, 2014. An electronic version of Mindray,s Annual ... investor relations website at  http://ir.mindray.com  or  http://www.sec.gov . ...
(Date:4/16/2015)... -- Mallinckrodt plc (NYSE: MNK ), a ... has completed its acquisition of Ikaria, Inc. at ... Ikaria acquisition extends Mallinckrodt,s footprint in the hospital ... care with INOMAX ® (inhaled nitric oxide), ... patient population. It also accelerates Mallinckrodt,s rapid growth ...
Breaking Medicine Technology:Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2Mallinckrodt Completes Acquisition Of Ikaria 2Mallinckrodt Completes Acquisition Of Ikaria 3Mallinckrodt Completes Acquisition Of Ikaria 4Mallinckrodt Completes Acquisition Of Ikaria 5
... 2, 2011 Nile Therapeutics, Inc. (Nasdaq: ... novel therapeutics for heart failure patients, today announced that, ... determination from the NASDAQ Listing Qualifications Panel (the "Panel") ... for an extension to remain listed on The NASDAQ ...
... 2011 Pacira Pharmaceuticals, Inc., (Nasdaq: ... announced that positive results from its Phase 1 ... patients with moderate hepatic impairment, will be presented ... and Therapeutics (ASCPT) 112th Annual Meeting in Dallas, ...
Cached Medicine Technology:Nile Therapeutics Receives Positive NASDAQ Panel Decision 2Nile Therapeutics Receives Positive NASDAQ Panel Decision 3Pacira Pharmaceuticals' EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting 2Pacira Pharmaceuticals' EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting 3
(Date:4/17/2015)... 17, 2015 As a board-certified orthopedic ... new offering of platelet-rich plasma (PRP) and ... is known for its world-class care of injury-caused ... surgical experience lacking in many other physicians offering regenerative ... are utilized for pain management and rehabilitation. Dr. Meier ...
(Date:4/17/2015)... 17, 2015 Baptist Health and The ... a partnership agreement designed to transform oncology care in ... have agreed to create a joint cancer program to ... translational research. Baptist MD Anderson Cancer Center is anticipated ... single destination for highly coordinated, multidisciplinary cancer care for ...
(Date:4/17/2015)... 2015 Connie Casad, M.D., a well-known ... advocate with 30 years of practice experience in Dallas, ... level of service for her patients with the availability ... recommended wellness books with a brief synopsis on each ... her interest in providing this service, Dr. Casad said, ...
(Date:4/17/2015)... 2015 Oxytocin is a ... and thought to help mothers bond to their newborn, ... substantiate this, new studies performed, at NYU Langone Medical ... reported by Medical News Today on April 16, 2015, ... maternal social behavior. The study reveals that, when oxytocin ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Ticket Down is a ... their 2015 Summer Tour. , The life of last-minute show announcements ... the popular group perform during the early part of 2015, but ... Will Wait,” “Little Lion Man,” “The Cave,” and “Believe,” will perform ... on June 2 at MCU Park at Coney Island in Brooklyn, ...
Breaking Medicine News(10 mins):Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 2Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 3Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:Connie Casad, M.D. Provides Patients Recommended List of Wellness Books on Website 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 3Health News:Mumford and Sons Tickets in Clarkston/Detroit, Raleigh, Columbia/Baltimore, Chicago, Mansfield/Boston, Brooklyn, Calgary and Edmonton Now On Sale 2
... Teenagers and young adults with cancer are being ... trials with the 13-24 age group in mind and ... to those trials that do exist, according to new ... University College Hospital, London, told Teenage Cancer Trust,s Fifth ...
... June 2008 A 115-year-old woman who remained mentally ... with little or no evidence of Alzheimer,s disease, according ... of Aging ( http://neurobiologyofaging.org/ ). , The findings question ... dementia will inevitably develop, if people live long enough. ...
... specialist nurse clinic rather than a consultant-led clinic for ... and good symptom management, according to a paper in ... , And because the clinical nurse specialist was ... consultations without referring issues to the consultant, patients also ...
... Gentag, Inc. and MacroArray,Technologies, LLC have entered into ... Gentag,s cell phone communication,technology and MacroArray,s urine diagnostic ... males are at risk of developing prostate cancer, ... order to simplify and expand,the use of low ...
... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer ... services, today noted that several key opinion ... Medical products and related,procedures during the scientific ... Invasive Cardiothoracic Surgery (ISMICS) annual,meeting in Boston., ...
... (NASDAQ: QLTI; TSX:,QLT) announced today that QLT USA, ... purchase agreement with Allergan Sales, LLC, a,wholly-owned subsidiary ... fully divest QLT,s,worldwide rights to Aczone(R), a prescription ... for the treatment of acne vulgaris. Under the,terms ...
Cached Medicine News:Health News:Organizers of cancer clinical trials are neglecting teenagers and young adults 2Health News:Organizers of cancer clinical trials are neglecting teenagers and young adults 3Health News:World's oldest woman had normal brain 2Health News:Specialist nurses can play a key role in supporting patients having radiotherapy 2Health News:Specialist nurses can play a key role in supporting patients having radiotherapy 3Health News:Gentag, Inc. and MacroArray Technologies Join Forces 2Health News:ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations 2Health News:ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations 3Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 2Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 3Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 4Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 5
The workhorse electric system....
... The BD Safety Knife with BD Xstar ... shield that protects the blade in prodedure ... is based on a grind-less process for ... yields outstanding sharpness and consistency. The ...
... Safety Knife with BD Xstar Blade includes ... protects the blade in prodedure and handling. ... on a grind-less process for manufacturing surgical ... sharpness and consistency. The arch style, ...
... The BD Safety Knife with BD ... retractable shield that protects the blade in ... technology is based on a grind-less process ... process yields outstanding sharpness and consistency. ...
Medicine Products: